Zobrazeno 61 - 70
of 395
pro vyhledávání: ''
Publikováno v:
Gut. 65:A126.1-A126
Introduction Small intestinal bacterial overgrowth (SIBO) negatively affects both the structure and function of the small intestine leading to a number of acute and chronic symptoms. The lactulose hydrogen breath test (LHBT) is commonly used to detec
Autor:
Mahesh Bhalme, CS Kwok
Publikováno v:
Gut. 65:A269.1-A269
Introduction Acute variceal haemorrhage (AVH) is associated with significant mortality risk. We conducted a prospective audit of patients admitted with AVH in the Northwest (NW) of England to examine our clinical practice and patient outcomes. Method
Autor:
André D'Hoore, Tim Vanuytsel, I. Demedts, Albert Wolthuis, Maura Corsetti, A Thys, Eveline Deloose, Jan Tack
Publikováno v:
Gut. 65:A49.1-A49
Introduction In clinical practice colonic manometry is recommended to exclude colonic inertia (no response to meal and to drug stimulation, i.e. bisacodyl) in patients with slow transit laxative-refractory constipation (Bharucha 2013). As to date, th
Publikováno v:
Gut. 65:A219.1-A219
Introduction Colonoscopy is the gold standard in the work-up of patients(pts) with suspected colon pathology. However, conventional colonoscopy is an invasive procedure, associated with certain risks/adverse events and/or occasionally contraindicated
Publikováno v:
Gut. 65:A194.1-A194
Introduction Chronic radiation proctopathy (CRP) is a recognised complication of pelvic radiotherapy. Symptoms include diarrhoea, rectal pain, bleeding and tenesmus. In 2014, we set up an enhanced, dedicated, multidisciplinary, specialist service for
Publikováno v:
Gut. 65:A140.2-A141
Introduction Although deranged liver function tests(LFTs) are seen in around 1/3 of patients with IBD at some point during the course of their disease,there is a lack of clarity over how this should be investigated and managed. Methods IBD patients a
Autor:
P Dunne, SB Laursen, L Laine, H Dalton, JH Ngu, M Schultz, I Murray, A Rahman, A Anderloni, A Stanley
Publikováno v:
Gut. 65:A12.1-A12
Introduction Anti-thrombotics (antiplatelets and anticoagulants; ATs) have been identified as risk factors for upper gastrointestinal bleeding (UGIB). However few international studies have evaluated their effect on patient outcome. We aimed to asses
Publikováno v:
Gut. 65:A267.2-A268
Introduction NICE guidance in 2000 (TA14) only recommended treatment of patients with moderate/severe HCV. NICE now advises that patients with G3 early disease should not be given DAAs but be treated with pegylated interferon/ribavirin, which is a lo
Publikováno v:
Gut. 65:A209.1-A209
Introduction C.difficile-induced diarrhoea is often refractory to treatment and can be life-threatening. As yet, there is no prospectively derived tool with which to predict treatment failure (TF) in C.difficile infection (CDI). We performed a fully
Publikováno v:
Gut. 65:A8.1-A8
Introduction The Composite Caecal Intubation Rate (CIR c ) has been proposed as a more pragmatic colonoscopy performance index, encompassing three key components; caecal intubation rate (CIR), patient comfort and sedation dose. 1 We calculated CIR c